Prelude Capital Management, LLC Amarin Corp Plcuk Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.19 - $2.19 $35,700 - $65,700	30,000 New	30,000 $45,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $17,160 - $29,691	-1,231 Reduced 98.48%	19 $0
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $460,995 - $768,657	-33,189 Reduced 96.37%	1,250 $19,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $531,850 - $670,451	32,689 Added 1867.94%	34,439 $668,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $22,067 - $39,077	1,750 New	1,750 $36,000
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $10,404 - $13,906	-3,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $10,302 - $12,648	3,400	3,400 $12,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.